MedTrace Logo

Perianal Abscess Packing Randomized ControlledTrial Pilot Study

NCT01853267 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2014-05-21

No results posted yet for this study

Summary

TITLE Perianal Abscess Packing (PAP): a randomised controlled trial (Pilot study)

DESIGN Randomised controlled trial.

HYPOTHESIS In patients with perianal abscesses incision and drainage without packing the subsequent cavity will reduce patient discomfort without increasing healing time or recurrence compared with management involving cavity packing.

OUTCOME MEASURES

* Length of hospital stay
* Time to cavity healing
* Recurrent abscess or fistula formation
* Pain score
* Analgesia usage POPULATION All patients older than 18 years presenting with a perianal abscess.

ELIGIBILITY Exclusion criteria:

* under 18 years
* those unable to give informed consent
* abscesses associated with Crohn's disease or other underlying causes
* abscesses in which initial drainage is considered inadequate (if the skin is not open sufficiently to allow drainage of the abscess cavity)

DURATION Until recruitment of subjects is complete

Conditions

  • Perianal Abscess

Interventions

PROCEDURE

Intervention Group (Non-Packing)

The haemostatic pack placed in the perianal abscess cavity will be removed on discharge and the wound will be left to heal without packing in situ

PROCEDURE

Control group (Packing)

After the procedure the abscess cavity will be packed with a non-adherent dressing as per standard treatment and the packing changed at regular intervals in the community until healing by secondary intention is complete.

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Paraskevas Paraskevas, MBBS · Department of Surgery and Cancer, Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01853267 on ClinicalTrials.gov